BridgeBio, BMS Set Sail In Expanded SHP2 Collaboration

 
• By Alaric DeArment
  
BridgeBio and BMS announced an expansion to their partnership to develop SHP2 inhibitor BBP-398 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category